Fulminant hepatitis as a consequence of reactivation of hepatitis B virus infection after discontinuation of low-dose methotrexate therapy

Ann Intern Med. 1990 Mar 1;112(5):381-2. doi: 10.7326/0003-4819-112-5-381.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Carrier State / immunology*
  • Female
  • Hepatitis B / etiology*
  • Hepatitis B / immunology
  • Hepatitis B virus / drug effects*
  • Hepatitis B virus / growth & development
  • Humans
  • Methotrexate / administration & dosage
  • Methotrexate / adverse effects*
  • Middle Aged
  • Substance Withdrawal Syndrome / immunology
  • Substance Withdrawal Syndrome / microbiology*
  • Virus Activation / drug effects*
  • Virus Activation / immunology

Substances

  • Methotrexate